Search

Your search keyword '"Zoster vaccine"' showing total 1 results
Start Over Descriptor "Zoster vaccine" Region beijing (china)
1 results on '"Zoster vaccine"'

1. LZ901, A Recombinant Herpes Zoster Vaccine And The Core Product Of Luzhu Biotechnology, Completed Phase II Clinical Trail In Q2 2023.

Subjects
HERPES zoster vaccines, BIOTECHNOLOGY, DNA virus diseases, CHICKENPOX, CLINICAL trials, HERPESVIRUS diseases, HERPES zoster
Abstract

Beijing Luzhu Biotechnology Co. Ltd., Biological Products, Biotechnology, Business, Chickenpox Vaccines, Clinical Research, Clinical Trials and Studies, DNA Virus Infections, DNA Viruses, Genetics, Health and Medicine, Herpes Zoster, Herpes Zoster Vaccine, Herpes Zoster Virus, Herpesviridae Infections, Herpesvirus, Herpesvirus Diseases and Conditions, Herpesvirus Vaccines, Immunization, Immunization and Public Health, Vaccines, Varicella Vaccines, Viral Vaccines, Virology, Zoster Vaccine. [Extracted from the article]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results